Search bioRxivSearch

bioRxiv · 10.1101/403683

General aspects of visceral leishmaniasis with or without HIV co-infection in Northeast Brazil

Abstract

BackgroundThe case of visceral leishmaniasis (VL) and human immunodeficiency virus (HIV) co-infection was reported in Spain first in 1985, and coincidence of these diseases has also been confirmed in more than 35 countries.\n\nMethodologyWe performed a comparative study in the states reference hospital for infectious/parasitic diseases, which treats adults with HIV/acquired immune deficiency syndrome (AIDS), between January 2007 and July 2017. The data obtained using this protocol were analyzed using SPSS.\n\nPrincipal findingsIn total, 163 patients were evaluated in this study, including 126 patients with coincident VL/HIV and 37 patients with VL alone. Both groups consisted primarily of male patients. The most commonly affected age group was 30-39 years (p < 0.001). Fever (p < 0.001) and hair loss (p = 0.007), which were more common in patients with VL alone, were more common. On hemogram, segmented neutrophils (p < 0.0001) were found to be more in the VL/HIV group than in the VL alone group. Additionally, AST and ALT levels differed between the groups (p < 0.001). On average, HIV was diagnosed 2.6 years before VL (p < 0.001). VL relapse was observed only in the co-infection group (36.5% of cases). Fever ({beta} = +0.17; p = 0.032) in the first VL/HIV episode was identified as a risk factor for relapse (R2 = 0.18). The death rate of co-infected patients was 11.1%.\n\nConclusion/SignificanceVL/HIV was prevalent among young adults, whereas the median patient age was higher in the VL group. The classic symptomatology of VL was more common in patients not co-infected with HIV, but attention is needed regarding the presence of fever in the first episode of VL as a risk factor for relapse in co-infected patients. No cases of VL relapse occurred in patients without HIV.\n\nAUTHOR SUMMARYVisceral Leishmaniasis (VL) and HIV have maintained increasing rates of populational occurrence in the Northeast region of Brazil, with advancing in rural areas and VL advancing in urban areas. This dynamic explains the increase of co-infection from 0.7% in 2001 to 8.5% in 2012. The state of Maranhao presents a large number of cases in the Northeast Brazil, a region with the majority of patients with this co-infection. The severity presented by these patients, in the observation of frequent relapses and high lethality, is presented in this study, which contributes to epidemiological, clinical, laboratorial, and evolutionary knowledge, trying to demonstrate these in the statistical data. Therefore, it should be pointed out that young adult patients with HIV/AIDS who present with any cytopenia, with or without hepatosplenomegaly and accompanied by fever or not, must be investigated for VL.

Explore related subjects

Keep this discovery

BibTeXRIS

Azevedo, C. d. M., Silva de Lima, U. R., Vanolli, L., Moraes, E. C., Ithamar, J. S., Uiara Regina Silva de Lima Luciano Vanolli Elizabeth Coelho Morais Jorim Ithamar Severino and Concei,. 2018-08-29. General aspects of visceral leishmaniasis with or without HIV co-infection in Northeast Brazil. https://doi.org/10.1101/403683

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Translating surveillance data into incidence estimates

Monitoring a population for a disease requires the hosts to be sampled and tested for the pathogen. This results in sampling series from which to estimate the disease incidence, i.e. the proportion of hosts infected. Existing estimation methods assume that disease incidence is not changing between monitoring rounds, resulting in underestimation of the disease incidence. In this paper we develop an incidence estimation model accounting for epidemic growth with monitoring rounds sampling varying incidence. We also show how to accommodate the asymptomatic period characteristic to most diseases. For practical use, we produce an approximation of the model, which is subsequently shown accurate for relevant epidemic and sampling parameters. Both the approximation and the full model are applied to stochastic spatial simulations of epidemics. The results prove their consistency for a very wide range of situations.

epidemiology

The Swiss Primary Ciliary Dyskinesia registry: objectives, methods and first results

Primary Ciliary Dyskinesia (PCD) is a rare hereditary, multi-organ disease caused by defects in ciliary structure and function. It results in a wide range of clinical manifestations, most commonly in the upper and lower airways. Central data collection in national and international registries is essential to studying the epidemiology of rare diseases and filling in gaps in knowledge of diseases such as PCD. For this reason, the Swiss Primary Ciliary Dyskinesia Registry (CH-PCD) was founded in 2013 as a collaborative project between epidemiologists and adult and paediatric pulmonologists.\n\nThe registry records patients of any age, suffering from PCD, who are treated and resident in Switzerland. It collects information from patients identified through physicians, diagnostic facilities, and patient organisations. The registry dataset contains data on diagnostic evaluations, lung function, microbiology and imaging, symptoms, treatments, and hospitalizations.\n\nBy May 2018, CH-PCD has contacted 566 physicians of different specialties and identified 134 patients with PCD. At present this number represents an overall 1 in 63,000 prevalence of people diagnosed with PCD in Switzerland. Prevalence differs by age and region; it is highest in children and adults younger than 30 years, and in Espace Mittelland. The median age of patients in the registry is 25 years (range 5-73), and 49 patients have a definite PCD diagnosis based on recent international guidelines. Data from CH-PCD are contributed to international collaborative studies and the registry facilitates patient identification for nested studies.\n\nCH-PCD has proven to be a valuable research tool that already has highlighted weaknesses in PCD clinical practice in Switzerland. Development of centralised diagnostic and management centres and adherence to international guidelines are needed to improve diagnosis and management--particularly for adult PCD patients.

epidemiology

Perfect Counterfactuals for Epidemic Simulations

Simulation studies are often used to predict the expected impact of control measures in infectious disease outbreaks. Typically, two independent sets of simulations are conducted, one with the intervetnion, and one without, and epidemic sizes (or some related metric) are compared to estimate the effect of the intervention. Since it is possible that controlled epidemics are larger than uncontrolled ones if there is substantial stochastic variation between epidemics, uncertainty intervals from this approach can include a negative effect even for an effective intervention. To more precisely estimate the number of cases an intervention will prevent within a single epidemic, here we develop a single world approach to matching simulations of controlled epidemics to their exact uncontrolled counterfac-tual. Our method borrows concepts from percolation approaches prune out possible epidemic histories and create potential epidemic graph that can be realized to create perfectly matched controlled and uncontrolled epidemics. We present an implementation of this method for a common class of compartmental models, and its application in a simple SIR model. Results illustrate how, at the cost of some computation time, this method substantially narrows confidence intervals and avoids non-sensical inferences.

epidemiology